Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (4)
  • 2025 (7)
  • 2024 (5)
  • 2023 (14)
  • 2022 (10)
  • 2021 (7)
  • 2020 (6)
  • 2019 (6)
  • 2018 (1)

Subject

  • Drug Trafficking (385)
  • Synthetic drugs (189)
  • Guns/Weapons (93)
  • Overdose (59)
  • Arrests/Convictions - Major (52)
  • Major Law Enforcement Operation (36)
  • Diversion Division (35)
  • Gangs (35)
  • Take Back Day (34)
  • Pharmaceuticals/Pharmacists/Physicians (31)
  • Fake Pills (30)
  • Outreach/Drug Prevention (26)
  • Task Forces/Task Force Officers (22)
  • Seizures (Drugs/Property) (21)
  • Public and Media Affairs - also see Congressional Affairs (20)
  • Money Laundering (18)
  • Fentanyl Awareness (17)
  • OCDETF/Task Force (17)
  • Press Conferences (14)
  • Congressional Affairs (12)
  • Guilty Plea (12)
  • Fentanyl Free America (11)
  • Extraditions (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (10)
  • One Pill Can Kill (9)
  • Red Ribbon (9)
  • Terrorism (9)
  • Counterfeit Pills (8)
  • International/Foreign Operations (7)
  • Narcoterrorism (5)
  • Critical Incident (4)
  • Dark Web- Internet Trafficking (4)
  • Intergovernmental Affairs (4)
  • Campaigns (3)
  • Cartel (2)
  • HIDTA (2)
  • Scam Calls (2)
  • El Paso Intelligence Center (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Prescription Drugs (60)

Drug Name

  • Oxycodone (15)
  • Fentanyl (9)
  • Methamphetamine (4)
  • Amphetamines (2)
  • Cocaine (2)
  • Opioids (2)
  • Benzodiazepines (1)
  • GHB (1)
  • Heroin (1)
  • Ketamine (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Morphine (1)
  • Psilocybin (1)

Field Division

  • Atlanta (19)
  • Chicago (16)
  • Dallas (15)
  • Detroit (3)
  • El Paso (15)
  • Houston (12)
  • Los Angeles (10)
  • Louisville (13)
  • Miami (19)
  • New England (24)
  • New Jersey (15)
  • New Orleans (8)
  • New York (36)
  • Omaha (12)
  • Philadelphia (1)
  • Phoenix (6)
  • Rocky Mountain (8)
  • San Diego (6)
  • San Francisco (15)
  • Seattle (26)
  • Sede (24)
  • St. Louis (42)
  • Washington, DC (45)
Clear All Results
60 Results - Showing 1 to 10
PRESS RELEASE

Texas Doctor Convicted for Illegally Distributing More than a Million Pills

WASHINGTON D.C. - A federal jury in the Southern District of Texas convicted a Texas physician yesterday for unlawfully distributing more than a million pills of opioids and other dangerous controlled substances. “Medical physicians who exploit their prescribing authority for profit over patient care break an inherent trust with their...
PRESS RELEASE

Glen Head Doctor and His Son Charged with Illegally Selling Prescriptions for Controlled Substances

MINEOLA, N.Y. – Drug Enforcement Administration New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Glen Head doctor and his son were charged with allegedly selling dozens of prescriptions for opioids, amphetamines, and benzodiazepines without a legitimate medical...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Pill Press Machines, Over 16lbs of Alleged Fentanyl, Meth, Cocaine and Oxycodone Recovered in Queens: Three Arrested

Queens, N.Y. - Three men were charged with participating in a narcotics trafficking operation following an investigation that ran for several months and resulted in the seizure of three illegal pill pressing machines and over four kilograms (10 pounds) of fentanyl in powder and pill form from a residence in...
PRESS RELEASE

DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

NEW YORK –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, 122 collection sites in...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster